npj Precision Oncology

npj Precision Oncology banner

Potential utility of risk stratification for multicancer screening with liquid biopsy tests

Elle S. Kim
Robert B. Scharpf
Nilanjan Chatterjee

Brief Communication 22 April 2023

Featured

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Jessica A. Scarborough
Steven A. Eschrich
Jacob G. Scott
ArticleOpen Access19 Apr 2023
Self-supervised attention-based deep learning for pan-cancer mutation prediction from histopathology

Oliver Lester Saldanha
Chiara M. L. Loeffler
Jakob Nikolas Kather
Brief CommunicationOpen Access28 Mar 2023
Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

Fergus Keane
Raazi Bajwa
Eileen M. O’Reilly
Case ReportOpen Access22 Apr 2023
Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

Omar Alhalabi
Roman Groisberg
Vivek Subbiah
ProtocolOpen Access18 Apr 2023

Announcements

Submit to our new Collection: AI in Precision Oncology

Deadline: 19 October 2023

Open for submissions
npj Precision Oncology Journal Metrics

npj Precision Oncology has a 2-year impact factor of 10.092 (2021), article downloads of 431,304 (2021) and 5 days from submission to the first editorial decision (2021).
Nature Portfolio Cancer Community

Discover more about utilizing AI for precision oncology in a Behind the Paper post from Author Istvan Petak

Browse articles

Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data

Melissa Zhao
Mai Chan Lau
Shuji Ogino
ArticleOpen Access10 Jun 2023
Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance

Mandy Sakamoto
Tejas Patil
Case ReportOpen Access08 Jun 2023
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition

Hanwen Wang
Theinmozhi Arulraj
Aleksander S. Popel
ArticleOpen Access08 Jun 2023
Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations

Tian-Gen Chang
Yingying Cao
Eytan Ruppin
ArticleOpen Access03 Jun 2023
CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma

Bolin Song
Kailin Yang
Anant Madabhushi
ArticleOpen Access02 Jun 2023
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer

Cristian Barrera
Germán Corredor
Anant Madabhushi
ArticleOpen Access01 Jun 2023
HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients

Lei Li
Yu Gu
Han Liang
ArticleOpen Access31 May 2023
High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Shu-Biao Ye
Yi-Kan Cheng
Ping Lan
ArticleOpen Access31 May 2023
Deep learning generates synthetic cancer histology for explainability and education

James M. Dolezal
Rachelle Wolk
Alexander T. Pearson
ArticleOpen Access29 May 2023

Editorial policies

For Authors and Referees

Trending - Altmetric

Jobs

Faculty Positions at SUSTech School of Medicine

Southern University of Science and Technology (SUSTech) is a public research university funded by Shenzhen city. Widely regarded as a pioneer and i...

Shenzhen

Southern University of Science and Technology (SUSTech)
Postdoctoral Fellow - The Laboratory of Prof. Naoto Hirano

The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developi...

Hong Kong (HK)

Centre for Oncology and Immunology
Postdoc in Machine Learning for Cancer Pharmacogenomics

APPLICATION CLOSING DATE: July 3rd, 2023 Human Technopole (HT) is a new interdisciplinary life science research institute, created and supported by...

Milan (IT)

Human Technopole
Postdoctoral Fellow - The Laboratory of Prof. Tracy McGaha

The long-term objective of the Centre for Oncology and Immunology is to identify druggable cancer targets of recalcitrant malignancies and developi...

Hong Kong (HK)

Centre for Oncology and Immunology
Professorship for Experimental Oncology (W3)

The Jena University Hospital (JUH) invites applications for a Professorship for Experimental Oncology (W3) to be filled at the earliest possible da...

07743, Zentrum (DE)

Friedrich-Schiller-Universität Jena

Advertisement

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Search

Advanced search

Quick links